1.
Liedtke M, Twist CJ, Medeiros BC, Gotlib JR, Berube C, Bieber MM, Bhat NM, Teng NN, Coutre SE. Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Haematologica [Internet]. 2011Dec.30 [cited 2026Nov.16];97(1):30-7. Available from: https://haematologica.org/article/view/6186